Research programme: infectious diseases vaccines - iBio/Immunological Technology Institute

Drug Profile

Research programme: infectious diseases vaccines - iBio/Immunological Technology Institute

Alternative Names: Yellow fever vaccine - iBio/Immunological Technology Institute

Latest Information Update: 25 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Immunobiological Technology Institute; Oswaldo Cruz Foundation
  • Class Recombinant proteins; Vaccines
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Yellow fever

Most Recent Events

  • 25 Jul 2016 Preclinical development is ongoing in Brazil (iBio pipeline, July 2016)
  • 17 Jun 2014 iBio, Bio-Manguinhos/Fiocruz and Fraunhofer USA Centre for Molecular Biotechnology expand their collaboration agreement for development of recombinant vaccines for Yellow fever
  • 19 Jan 2011 Preclinical trials in Yellow fever in Brazil (parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top